Skip to main content
123 Results For "leishmaniasis"
 
Myanmar, Dawei - MSF treats first CMVR patients with oral drug
HIV/AIDS

Visceral Leishmaniasis as an AIDS Defining Condition: Towards Consistency across WHO Guidelines

A publication on visceral-leishmaniasis-HIV co-infection. Journal article - 17 Jul 2014
 
MSF team works desparately to save life
HIV/AIDS

Visceral Leishmaniasis and HIV Coinfection in East Africa

Visceral Leishmaniasis (VL) is an important protozoan opportunistic disease in HIV patients in endemic areas. Journal article - 26 Jun 2014
 
Kala azar

Hypokalaemia-Induced Rhabdomyolysis after Treatment of Post-Kala-azar Dermal Leishmaniasis (PKDL) with High-Dose AmBisome in Bangladesh - A Case Report

Hypokalaemia-Induced Rhabdomyolysis after Treatment of PKDL with High-Dose AmBisome in Bangladesh - A Case Repor Journal article - 20 Jun 2014
 
Kala Azar in Bihar, India. Sadar Hospital, Vaishali District.
India

Better detection, diagnosis and treatment needed for neglected complication of kala azar in Bihar

MSF is calling on the Bihar government and NVBDCP to recognise and treat Post Kala azar Dermal Leishmaniasis. Press Release - 10 Apr 2014
 
Kala Azar in Bihar, India
India

Access to kala azar treatment in public healthcare system needs to be scaled up

MSF successfully tackles kala azar in Bihar state, India Project Update - 28 Mar 2014
 
Kala Azar in Bihar, India
Kala azar

Clinical Epidemiology, Diagnosis and Treatment of Visceral Leishmaniasis in the Pokot Endemic Area of Uganda and Kenya

Between 2000 and 2010, Médecins Sans Frontières diagnosed and treated 4,831 patients with visceral leishmaniasis (VL, also known as kala azar) in the Pokot region straddling the border between Uganda and Kenya. Journal article - 8 Jan 2014
Kala azar

Five-Year Field Results and Long-Term Effectiveness of 20 mg/kg Liposomal Amphotericin B (Ambisome) for Visceral Leishmaniasis in Bihar, India

MSF kala azar treatment project in Bihar using 20 mg/Kg intravenous liposomal amphotericin B. Journal article - 2 Jan 2014
 
Syria

Open letter to all States and non-State actors involved in the conflict

MSF calls on US and Russia to place at the top of their diplomatic agendas the substantial scale up of humanitarian aid to millions of war-affected Syrians. Open Letter - 27 Sep 2013
 
MSF HOSPITAL, IDLIB Region, SYRIA
Syria

Open letter: let us treat patients in Syria

In an open letter published on Monday 16 September 2013, a coalition of over 50 eminent doctors warns of a medical catastrophe in Syria and calls for medical and humanitarian access to those suffering. Open Letter - 16 Sep 2013
 
Influx of Syrians into Domeez Camp, Iraq
Syria

MSF speech at the UN Syria donor conference

Speech delivered by Dr Mego Terzian, MSF president, at the UN donor meeting on Syria. Speech - 7 Jun 2013
Cholera intervention in South Kivu
Médecins Sans Frontières (MSF)

Independent medical humanitarian assistance

We provide medical assistance to people affected by conflict, epidemics, disasters, or exclusion from healthcare. Our teams are made up of tens of thousands of health professionals, logistic and administrative staff - most of them hired locally. Our actions are guided by medical ethics and the principles of independence and impartiality. We are a non-profit, self-governed, member-based organisation.

Learn more